Sci-ROI Connect
Volume 10 | May 18, 2021
Sci-ROI initiative
We are excited to introduce you to our new logo reflecting our objectives to expand globally beyond our current reach in USA. Sci-ROI has taken recent initiatives to cater to the Indian diaspora in different regions of the world such as Europe, UK and Asia pacific. We encourage you to spread the words in your community that our round the year activities, focused webinars, annual event and recruitment drives are now open to the entire STEM professionals who are currently residing abroad and aspiring to transition back to India. Our versatile graphic designing team has brainstormed on that idea and come up with a unique logo for Sci-ROI reflecting the knowledge circulation back to India from the experts around the globe. Visit us for more career related opportunities at
Sci-ROI is organizing an in-depth webinar on 22nd May, Saturday for anyone who is looking to transition to Indian industry from an academic position. This webinar will have successful R&D personnel in various Indian companies sharing their experiences on —

  • How to tailor your CV? -highlight your academic, technical and non-technical skills

  • What additional skills to gain? - leadership, commercial awareness, communication skills

  • Interview tips, tricks and background work, and much more!
Presentation by speakers will be followed by a panel discussion including industry expert and talent acquisition manager. If you have any questions on how to transition for an academic position to industry, this webinar will answer them all! Register today at
Sci-ROI is excited to announce that the registration for the 2nd virtual recruitment drive is now open till May 24th. The virtual recruitment drive intends to bring together well-qualified Indian STEM professionals residing abroad and recruiters from reputable Indian institutes.

So far nine institutes from India - IIT-Gandhinagar, IIT-Roorkee, IIIT-Delhi, Ahmedabad University, Ashoka, Amrita, Plaksha, UPES and GITAM have confirmed their participation in this drive and will be engaging with the shortlisted candidates in 1-to-1 interviews.
We are in talks with more recruiters to update the list further. If you are currently outside India, actively looking for positions in Indian STEM sector, you will not want to miss this unique career opportunity.

Do you have questions on what the recruitment drive entails? Want to apply but not sure where to start? Want to know more about the positions offered by the participating institutes? Sci-ROI is conducting an informal Q&A session where you can ask the organizers anything about the recruitment drive. Please join us on May 22nd, 2:00 PM ET by registering at this link.

For more details and registration for the recruitment drive, please visit
Indian scientific research is growing at a rapid pace. New policies are being made and facilities are being developed to pursue different avenues of cutting-edge research. ‘Evolving Trends in India’ series explores different aspects of the growing Indian research, showcasing the progress being made and providing suggestions for further improvement.

In the first blog of this series, Rohit VaidyaSci-ROI Blogs Team member, takes a closer look at interdisciplinary research in India.

Sci-ROI is inviting members to write blog articles with a focus on STEM sectors in India. We are looking at several ideas such as - New Faculty transition, Established Scientists in Indian academics, Current STEM events, Cutting edge Research in Indian Academia or Industry, Online STEM education, Creative STEM ventures, Start-up stories, Unique Careers and many more.

If you have any idea or unique story which you want to share with our members. please pitch them by writing to us at:
Volunteer's Corner
I am a botanist and biochemist by training. During my Ph.D. I worked on photosynthesis in green algae and manipulating crops with algal genes to manage global food shortage. Currently as a postdoctoral researcher, I work on small RNA mechanisms to understand neurodegenerative diseases better. I also write News and Views columns for the journal Plant Physiology where I simplify current research and provide background for readers. I also create microblogs for The Stem Times, a science communication Instagram group.

I learnt about Sci-ROI from some colleagues and attended the 2020 virtual meeting. Not only did I come away with a plethora of information about transitioning to India, I was also in awe of this community of volunteers working tirelessly to make transitions easier. The diversity of topics being discussed was also something worth appreciating- from academia to industry and non-traditional careers. It was amazing to be able to ask questions and interact with scientists in India who have also transitioned recently. I joined as a volunteer in Feb 2021 and kickstarted the Instagram account for Sci-ROI. I also assist our team in Sci-ROI Blogs.

Know more about Ananya here

Current Job Opportunities in India
Sci-ROI's job portal is dedicated for helping researchers and Ph.D. scholars accessing job opportunities in India. These job listings are targeted towards research, industry and entrepreneurship that may be of interest to the STEM community. Checkout some new additions to our Job Portal.
Current Affairs
Call for a national strategy to make biomedical research more human-relevant
A column article on IndiaBioscience Web platform written by P Surat
Scientists are increasingly lobbying for non-animal models for biomedical research, given that subtle genetic differences between humans and animals can lead to pronounced differences in disease severity. Advanced technologies such as organs-on-chips are showing potential to make biomedical research more human-relevant. Surat reports on a recent virtual event that initiated a dialogue on the possibilities and challenges of implementing human-relevant models and frameworks in India.

Read more here.
Govt to set up 20 shared technology, R&D centres in top IITs

These centres, named Sophisticated Analytical and Technical Help Institutes, will be professionally managed and will have strong science and technology infrastructure, financially supported by the department of science.

Read more
Indian biotech startup reports early cancer detection...

A team of Indian scientists says it has achieved a stunning breakthrough in early cancer diagnosis with a discovery rooted in a contentious segment of cellular biology that, if validated by additional trials, holds vast market potential in a branch..

Read more
Potential cancer drug repurposed for Covid-19 by DRDO,...

A potential cancer drug repurposed for Covid-19 treatment -- 2-deoxy-D-glucose (2-DG) - has received the Drugs Controller General of India nod for emergency use as adjunct therapy for hospitalized moderate to severe Covid patients.

Read more
From the Preface:
"It has been known since time immemorial that Indian medical science has been way ahead of its time and age and has also been at the helm of research and development of most advance drugs. Starting from Yoga and Ayurveda, the ancient medical practitioners were even capable of carrying out plastic surgery and other complex procedures. A few contributions from India to the world of medicine includes the likes of discovery of STIL gene, use of glue in eye surgeries, diabetic surgery, cyberknife technology, and polypill for heart.

Pivotal to life and survival, the Indian Medical Industry has braved every challenge and turned problems into opportunities to showcase its potential. Every other day the medical practitioners come across new diseases, which possess the potential to threaten the ways and existence of mankind. The ongoing COVID-19 pandemic has been yet another touchstone for the Indian medical industry and practitioners." Download full report here.
Covaxin effectively neutralises emerging variants...

Indigenous Covid-19 vaccine Covaxin has been able to neutralise all key emerging variants, including the double mutant B.1.617 and B.1.1.7, which was first identified in India and the UK, Bharat Biotech said. The company also said that no...

Read more
Citing a study published in peer-reviewed medical journal Clinical Infectious Diseases, Bharat Biotech joint managing director Suchitra Ella reported: “A modest reduction in neutralisation by a factor of 1.95 was observed against B.1.617 variant compared to the vaccine variant (D614G). Despite this reduction, neutralising titre levels with B.1.617 remain above levels expected to be protective.” Access the published article here.
'Swades' for scientists: The return to India journey

Many Indian researchers working abroad hope and plan to return to India to set up their independent labs in the future. However, they often find themselves stymied by a lack of information, both about the transition process and about the...

Read more
DU Selected for GATI Programme to Promote Gender Equality...

The University of Delhi (DU) has been selected as a participant in the pilot of Gender Advancement for Transforming Institutions (GATI), a programme launched by the Department of Science and Technology (DST)...

Read more
Sci-ROI 2021 Sponsor
If you want to share any information or upcoming event, please write to us at

Your donations assist us in enriching the Indo-US scientific communication.
Click here to donate.